IL98543A - Endonuclease and its use in the cleavage of a target nucleic acid sequence - Google Patents

Endonuclease and its use in the cleavage of a target nucleic acid sequence

Info

Publication number
IL98543A
IL98543A IL9854391A IL9854391A IL98543A IL 98543 A IL98543 A IL 98543A IL 9854391 A IL9854391 A IL 9854391A IL 9854391 A IL9854391 A IL 9854391A IL 98543 A IL98543 A IL 98543A
Authority
IL
Israel
Prior art keywords
cleavage
endonuclease
nucleic acid
acid sequence
deoxyribonucleotides
Prior art date
Application number
IL9854391A
Other languages
English (en)
Other versions
IL98543A0 (en
Original Assignee
Gene Shears Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Shears Pty Ltd filed Critical Gene Shears Pty Ltd
Publication of IL98543A0 publication Critical patent/IL98543A0/xx
Publication of IL98543A publication Critical patent/IL98543A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Dram (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Detection And Prevention Of Errors In Transmission (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Coating By Spraying Or Casting (AREA)
IL9854391A 1990-06-19 1991-06-18 Endonuclease and its use in the cleavage of a target nucleic acid sequence IL98543A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK067990 1990-06-19
AUPK400290 1990-12-21

Publications (2)

Publication Number Publication Date
IL98543A0 IL98543A0 (en) 1992-07-15
IL98543A true IL98543A (en) 2000-02-17

Family

ID=25643889

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9854391A IL98543A (en) 1990-06-19 1991-06-18 Endonuclease and its use in the cleavage of a target nucleic acid sequence

Country Status (11)

Country Link
US (3) US5298612A (de)
EP (1) EP0535067B1 (de)
JP (1) JPH05509224A (de)
KR (1) KR930701590A (de)
AT (1) ATE150789T1 (de)
CA (1) CA2084790C (de)
DE (1) DE69125374T2 (de)
FI (1) FI925715A0 (de)
IL (1) IL98543A (de)
NZ (1) NZ238614A (de)
WO (1) WO1991019789A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365730B1 (en) * 1990-06-19 2002-04-02 Gene Shears Pty. Limited DNA-Armed ribozymes and minizymes
WO1992007065A1 (en) 1990-10-12 1992-04-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Modified ribozymes
US6041910A (en) * 1997-09-22 2000-03-28 Jervis B. Webb Company Baggage pusher device and system
US5652094A (en) * 1992-01-31 1997-07-29 University Of Montreal Nucleozymes
US5484589A (en) * 1992-04-20 1996-01-16 Rufeld, Inc. Anti-viral methods using RNAse and DNAse
US5610054A (en) * 1992-05-14 1997-03-11 Ribozyme Pharmaceuticals, Inc. Enzymatic RNA molecule targeted against Hepatitis C virus
US5599704A (en) * 1992-08-26 1997-02-04 Ribozyme Pharmaceuticals, Inc. ErbB2/neu targeted ribozymes
US5891684A (en) * 1992-10-15 1999-04-06 Ribozyme Pharmaceuticals, Inc. Base-modified enzymatic nucleic acid
ZA938208B (en) * 1992-11-03 1995-01-03 Gene Shears Pty Ltd TNF-alpha ribozymes and degradation resistant mRNA derivatives linked to TNF-alpha ribozymes
GB9225427D0 (en) * 1992-12-04 1993-01-27 Ribonetics Gmbh Oligonucleotides with rna cleavage activity
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
WO1995006731A2 (en) * 1993-09-02 1995-03-09 Ribozyme Pharmaceuticals, Inc. Non-nucleotide containing enzymatic nucleic acid
AU5334294A (en) * 1993-10-15 1995-05-04 Dkfz Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Asymmetric hammerhead ribozymes and nucleotide sequences for their construction
US5861288A (en) * 1993-10-18 1999-01-19 Ribozyme Pharmaceuticals, Inc. Catalytic DNA
AU687479B2 (en) 1993-11-08 1998-02-26 Ribozyme Pharmaceuticals, Inc. Base-modified enzymatic nucleic acid
JPH09510101A (ja) * 1994-03-07 1997-10-14 イミュソル，インコーポレイティド 再狭窄のためのリボザイム療法
WO1995024477A1 (en) * 1994-03-08 1995-09-14 City Of Hope Human papillomavirus targeted ribozymes
US5998193A (en) * 1994-06-24 1999-12-07 Gene Shears Pty., Ltd. Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
US5672501A (en) * 1994-12-23 1997-09-30 Ribozyme Pharmaceuticals, Inc. Base-modified enzymatic nucleic acid
US5663064A (en) * 1995-01-13 1997-09-02 University Of Vermont Ribozymes with RNA protein binding site
US5872241A (en) * 1995-01-25 1999-02-16 The Trustees Of Columbia University In The City Of New York Multiple component RNA catalysts and uses thereof
US6004806A (en) * 1995-06-07 1999-12-21 Commonwealth Scientific And Industrial Research Organization Optimized minizymes and miniribozymes and uses thereof
EP0837933A4 (de) * 1995-06-07 2003-05-21 Commw Scient Ind Res Org Optimierte minizyme und miniribozyme und deren anwendungen
JP2000501284A (ja) * 1995-11-14 2000-02-08 ビムラックス ホールディングズ，リミテッド Ｒｎａ切断活性を有するキメラオリゴマー
US5728818A (en) * 1996-01-16 1998-03-17 Ribozyme Pharmaceuticals, Inc. Chemical linkage of ribozyme protions
AU721758B2 (en) * 1996-04-02 2000-07-13 Gene Shears Pty. Limited Asymmetric hammerhead ribozymes
JP2001518292A (ja) * 1997-09-22 2001-10-16 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ エンドヌクレアーゼ活性を有する核酸触媒
US6326193B1 (en) * 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
EP1292331A2 (de) * 2000-06-07 2003-03-19 Biosynexus Incorporated Immunstimulierende rns/dns hybridmolekule
AU2002359761A1 (en) 2001-12-18 2003-06-30 Invenux, Inc. Antibiotic compounds
WO2004055198A2 (en) * 2002-12-12 2004-07-01 Chiron Corporation Device and method for in-line blood testing using biochips
CA3034101A1 (en) * 2016-08-19 2018-02-22 Bluebird Bio, Inc. Genome editing enhancers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511713A (en) * 1980-11-12 1985-04-16 The Johns Hopkins University Process for selectively controlling unwanted expression or function of foreign nucleic acids in animal or mammalian cells
US5023243A (en) * 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
AU632993B2 (en) * 1987-12-15 1993-01-21 Gene Shears Pty. Limited Ribozymes
ATE140961T1 (de) * 1989-03-16 1996-08-15 Boehringer Ingelheim Int Genetische einheiten zur inhibierung der funktion von rna
US5149796A (en) * 1989-08-31 1992-09-22 City Of Hope Chimeric DNA-RNA catalytic sequences
DE3929741A1 (de) * 1989-09-07 1991-03-28 Hoechst Ag Rna mit endoribonucleaseaktivitaet gegen mrna von reifungsgenen, ihre herstellung und ihre verwendung in pflanzen

Also Published As

Publication number Publication date
JPH05509224A (ja) 1993-12-22
CA2084790A1 (en) 1991-12-20
US5972701A (en) 1999-10-26
WO1991019789A1 (en) 1991-12-26
US6001989A (en) 1999-12-14
DE69125374D1 (en) 1997-04-30
FI925715A7 (fi) 1992-12-16
EP0535067B1 (de) 1997-03-26
ATE150789T1 (de) 1997-04-15
NZ238614A (en) 1993-07-27
CA2084790C (en) 2002-04-09
FI925715A0 (fi) 1992-12-16
DE69125374T2 (de) 1997-10-23
EP0535067A4 (en) 1993-07-28
KR930701590A (ko) 1993-06-12
IL98543A0 (en) 1992-07-15
US5298612A (en) 1994-03-29
EP0535067A1 (de) 1993-04-07

Similar Documents

Publication Publication Date Title
IL98543A0 (en) Endonuclease and its use in the cleavage of a target nucleic acid sequence
Rohatgi et al. Nonenzymatic, Template-Directed Ligation of Oligoribonucleotides Is Highly Regioselective for the Formation of 3 ‘− 5 ‘Phosphodiester Bonds
Beaudry et al. An efficient strategy for the synthesis of circular RNA molecules
Li et al. Phosphorylating DNA with DNA
Noronha et al. Synthesis and biophysical properties of arabinonucleic acids (ANA): circular dichroic spectra, melting temperatures, and ribonuclease H susceptibility of ANA⊙ RNA hybrid duplexes
ATE261984T1 (de) N-2 substituierte purine
BR9809433A (pt) Moléculas de dna enzimáticas
DE3855864D1 (de) Durch modifikationen an der 3'-terminalen phosphodiesterbindung stabilisierte dna moleküle, ihre verwendung als nukleinsäuresonden sowie als therapeutische mittel zur hemmung der expression spezifischer zielgene
Braich et al. Regiospecific solid-phase synthesis of branched oligonucleotides. Effect of vicinal 2 ‘, 5 ‘-(or 2 ‘, 3 ‘-) and 3 ‘, 5 ‘-phosphodiester linkages on the formation of hairpin DNA
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
DE50114507D1 (de) Nukleinsäure-Linker und deren Verwendung in der Gensynthese
DK0721988T3 (da) Kimærisk oligonucleotid og dets anvendelse ved opnåelse af transkripter af en nucleinsyre
DE60140676D1 (de) Mediatoren von rns-interferenz, die rns-sequenzspezifisch sind
BR9904449A (pt) Processo para o preparo de ácido pantotênico através de amplificação de sequências de nucleotìdeos, as quais codificam a redutase de cetopantoato
DE69534855D1 (de) Enzymaktive dna moleküle
WO2002052031A3 (en) Nucleic acid amplification
ATE439437T1 (de) Verbessertes klonierungsverfahren
CA2264246A1 (en) Catalytic nucleic acid and its medical use
Chen et al. N2′→ P3′ phosphoramidate glycerol nucleic acid as a potential alternative genetic system
DK1053313T3 (da) Optimerede antisense oligonucleotider komplementære til DNA methyltransferase-sekvenser
ATE203775T1 (de) Methode zur detektion einer gezielten nukleinsäure
Hatahet et al. A novel method for site specific introduction of single model oxidative DNA lesions into oligodeoxyribonucleotides
JP7780951B2 (ja) ヌクレオチド修飾に基づく枯渇のための組成物及び方法
Zhang et al. Phototriggered formation and repair of DNA containing a site-specific single strand break of the type produced by ionizing radiation or AP lyase activity
PT1322753E (pt) Novas redutases do acido 2,5-diceto-l-gluconico e metodos de utilizacao

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees